Overview

Effects Of Additional MgSO4 30 Mg/KgBW Intravenous and Ketorolac

Status:
Completed
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
This study aims to compare two groups of post-orthopedic patients who received a standard regimen, namely ketorolac 30mg, to the second group, which was given the standard regimen and adjuvant magnesium sulfate 30mg/kgBW 1 hour preoperatively. If it is proven useful, it is hoped that pain will be more controlled, reduce pain complications, reduce treatment costs, and reduce the duration of hospital stays.
Phase:
Phase 4
Details
Lead Sponsor:
Indonesia University